Eczema breakthrough? postbiotic cream may keep Kids' skin calm

NCT ID NCT06474728

Completed Disease control Sponsor: Children's Hospital of Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a moisturizer containing postbiotic Saccharomyces and Lactobacillus can reduce the risk of eczema returning in children aged 0-6 years who are in remission. 98 children used either the special emollient or a standard one for 12 weeks. The goal was to see if the postbiotic cream could keep flare-ups away better than routine care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: emollient containing postbiotic Saccharomyces and Lactobacillus
What this could lead to: If it works, this could offer a natural way to prevent eczema flare-ups in young children without strong medications.
What could go wrong: This is a small, completed trial with 98 children, and the results may not apply to all cases. The effect may be modest or no better than standard moisturizers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS ECZEMA EMOLLIENT

Contacts and locations

Locations

Department of Dermatology,Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, 201102, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.